9580353

Clavero N??ez AJ

1997

[Hyperandrogenic ovary syndrome].

9580540

Gra?a-Barcia M

1998

Depression of FSH and LH secretion following pulsatile GnRH administration in ovariectomized women.

9588250

Chen C

1998

Troglitazone: an antidiabetic agent.

9589438

Campo S

1998

Ovulatory cycles, pregnancy outcome and complications after surgical treatment of polycystic ovary syndrome.

9589683

Lockwood GM

1998

Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergence of the dominant follicle.

9589685

Guido M

1998

Involvement of ovarian steroids in the opioid-mediated reduction of insulin secretion in hyperinsulinemic patients with polycystic ovary syndrome.

9596926

Liang X

1997

[The effects of hyperinsulinmia and insulin-like growth factor-1 on hyperandrogenism in polycystic ovarian syndrome].

9597623

Franks S

1998

Polycystic ovary syndrome.

9609208

Redmond GP

1998

Androgens and women's health.

9610422

Lidor A

1998

Combined somatostatin analog and follicle-stimulating hormone for women with polycystic ovary syndrome resistant to conventional treatment.

9618791

Franks S

1998

Etiology of anovulation in polycystic ovary syndrome.

9618792

Toscano V

1998

Hyperandrogenism in the adolescent female.

9619341

Davison RM

1998

New approaches to insulin resistance in polycystic ovarian syndrome.

9619530

Vrtacnik-Bokal E

1998

Utero-ovarian arterial blood flow and hormonal profile in patients with polycystic ovary syndrome.

9619535

Ciampelli M

1998

Acute insulin response to intravenous glucagon in polycystic ovary syndrome.

9619969

Talbott E

1998

Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study.

9622966

Hugues JN

1998

[Step protocols].

9623517

Ciampelli M

1998

Opioid blockade effect on insulin beta-cells secretory patterns in polycystic ovary syndrome. Oral glucose load versus intravenous glucagon bolus.

9626128

Cronin L

1998

Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS).

9626131

Nestler JE

1998

Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system.

9627309

Wu MH

1998

The role of three-dimensional ultrasonographic images in ovarian measurement.

9629628

Wolf AS

1998

[Obesity--significance in adolescence and for reproduction].

9629629

Geisth?vel F

1998

Obesity in female life--from molecular to clinical aspects.

9629633

Winkler UH

1998

[Obesity and thrombotic vascular diseases].

9630759

Sinagra D

1997

Feedback inhibition of insulin secretion and insulin resistance in polycystic ovarian syndrome with and without obesity.

9637806

Nestler JE

1998

Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome.

9639732

Wu X

1997

[Renin-angiotensin system: involvement in polycystic ovarian syndrome].

9639745

Wu X

1997

[Responses of growth hormone and prolactin to L-Dopa in women with polycystic ovarian syndrome].

9642371

Liang X

1997

[The secretion and receptor gene of insulin-like growth factor-I quantitative expression in ovarian stroma in polycystic ovarian syndrome patients].

9644450

Seibert DC

1998

Unraveling the mystery of chronic amenorrhea.

9644772

Battaglia C

1998

Ultrasonographic patterns of polycystic ovaries: color Doppler and hormonal correlations.

9648052

Katulski K

1998

Typical hormonal profiles are accompanied by increased immunoreactivity of theca folliculi steroid 17 alpha-hydroxylase P450 in polycystic ovary syndrome.

9648381

Pasquali R

1998

[Influence of weight and distribution of adipose tissue in functional hyperandrogenism].

9649084

Anttila L

1998

Polycystic ovaries in women with gestational diabetes.

9651456

Slyper AH

1998

Childhood obesity, adipose tissue distribution, and the pediatric practitioner.

9651655

Mor?n C

1998

Effect of clomiphene citrate on ovulation after treatment withdrawal.

9652605

Sattar N

1998

Insulin-sensitising agents in polycystic-ovary syndrome.

9658717

Tscherne G

1998

[Menstrual cycle anomalies in young girls--prognosis concerning later fertility].

9661602

Azziz R

1998

Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis.

9661606

Hayes FJ

1998

Use of a gonadotropin-releasing hormone antagonist as a physiologic probe in polycystic ovary syndrome: assessment of neuroendocrine and androgen dynamics.

9661609

Imani B

1998

Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility.

9661617

Fiad TM

1998

Decline in insulin-like growth factor I levels after clomiphene citrate does not correct hyperandrogenemia in polycystic ovary syndrome.

9661644

Morin-Papunen LC

1998

Decreased serum leptin concentrations during metformin therapy in obese women with polycystic ovary syndrome.

9666866

Cisternino M

1998

Exaggerated 17-hydroxyprogesterone response to short-term adrenal stimulation and evidence for CYP21B gene point mutations in true precocious puberty.

9666869

Anderson RA

1998

Inhibin A and inhibin B in women with polycystic ovarian syndrome during treatment with FSH to induce mono-ovulation.

9674665

Pierpoint T

1998

Mortality of women with polycystic ovary syndrome at long-term follow-up.

9678076

Halikias I

1997

Combined oral contraceptives and gonadotropin releasing hormone agonistic analogs in polycystic ovary syndrome: clinical and experimental studies.

9678118

Tarquini R

1996

Hypermelatoninemia in women with polycystic ovarian syndrome.

9683349

Cha KY

1998

Maturation in vitro of immature human oocytes for clinical use.

9685283

Hopkinson ZE

1998

Polycystic ovarian syndrome: the metabolic syndrome comes to gynaecology.

9686474

Meczekalski B

1997

[Leptin--missing link between the metabolic state and the reproductive system?].

9688367

Kyei-Mensah AA

1998

Relationship of ovarian stromal volume to serum androgen concentrations in patients with polycystic ovary syndrome.

9688372

van der Meer M

1998

Octreotide, a somatostatin analogue, alters ovarian sensitivity to gonadotrophin stimulation as measured by the follicle stimulating hormone threshold in polycystic ovary syndrome.

9692407

Conn JJ

1998

Managing hirsutism in gynaecological practice.

9693445

Dunaif A

1998

Polycystic ovary syndrome. Polycystic ovary syndrome.

9695768

Moussatov AG

1998

A possible approach to the treatment of polycystic ovarian syndrome using focused ultrasound.

9699325

Motta EL

1998

Ovarian activity before and after gonadal suppression by GnRH-a in patients with polycystic ovary syndrome, hyperandrogenism, hyperinsulinism and acanthosis nigricans.

9709933

Legro RS

1998

A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome.

9709934

Diamanti-Kandarakis E

1998

The effect of a pure antiandrogen receptor blocker, flutamide, on the lipid profile in the polycystic ovary syndrome.

9709959

Moghrabi N

1998

Deleterious missense mutations and silent polymorphism in the human 17beta-hydroxysteroid dehydrogenase 3 gene (HSD17B3).

9711989

Ciaraldi TP

1998

Lack of insulin resistance in fibroblasts from subjects with polycystic ovary syndrome.

9711997

Vicennati V

1998

Serum leptin in obese women with polycystic ovary syndrome is correlated with body weight and fat distribution but not with androgen and insulin levels.

9717459

Nandedkar TD

1998

Autoimmune disorders of the ovary.

9722324

Jacobs HS

1998

Reproductive endocrinology.

9722370

Geary M

1998

Childhood influences on adult disease.

9724074

Krassas GE

1998

Leptin levels in women with polycystic ovary syndrome before and after treatment with diazoxide.

9724684

Banerjee S

1998

Hormonal findings in African-American and Caribbean Hispanic girls with premature adrenarche: implications for polycystic ovarian syndrome.

9737067

Barr?n Vallejo J

1998

[A murine model of polycystic ovaries: its use in the evaluation of effects of endoscopic ovulation induction].

9741712

Ben-Shlomo I

1998

Hyperandrogenic anovulation (the polycystic ovary syndrome)--back to the ovary?

9745406

Knochenhauer ES

1998

Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study.

9751226

Bagavandoss P

1998

Transient induction of polycystic ovary-like syndrome in immature hypothyroid rats.

9753881

Martikainen H

1998

Polycystic ovary syndrome and hyperandrogenism as a risk factor for cardiovascular disease.

9756275

Johannesson M

1998

Female patients with cystic fibrosis suffer from reproductive endocrinological disorders despite good clinical status.

9758010

Karabacak O

1998

Is it polycystic ovary syndrome causing the hyperstimulation again?

9766266

Leondires MP

1998

Role of GnRH drive in the pathophysiology of polycystic ovary syndrome.

9769710

Legro RS

1998

Phenotype and genotype in polycystic ovary syndrome.

9770803

Tanchev S

1998

[The polycystic ovary syndrome--its diagnosis and the therapeutic approach].

9772595

Zhou LR

1996

[Clinical observation on treatment of hyperinsulinemia and hyperandrogenism anovulatory patient with replenishing kidney-yin drugs].

9784712

Kornats'ka AH

1998

[Local humoral immunity in women with combined forms of infertility].

9784936

Fr?hbeck G

1998

Leptin: physiology and pathophysiology.

9785710

Eberle AJ

1998

Valproate and polycystic ovaries.

9793185

Mason H

1998

Polycystic ovaries: question of definition.

9793190

Battaglia C

1998

Ultrasonographic and color Doppler analysis in the treatment of polycystic ovary syndrome.

9793191

Zaidi J

1998

Blood flow changes in the ovarian and uterine arteries in women with polycystic ovary syndrome who respond to clomiphene citrate: correlation with serum hormone concentrations.

9793192

Pinkas H

1998

Doppler parameters of uterine and ovarian stromal blood flow in women with polycystic ovary syndrome and normally ovulating women undergoing controlled ovarian stimulation.

9797093

Agrawal R

1998

Serum vascular endothelial growth factor and Doppler blood flow velocities in in vitro fertilization: relevance to ovarian hyperstimulation syndrome and polycystic ovaries.

9797110

Almahbobi G

1998

Hyperexpression of epidermal growth factor receptors in granulosa cells from women with polycystic ovary syndrome.

9797851

De Leo V

1998

Effects of flutamide on pituitary and adrenal responsiveness to corticotrophin releasing factor (CRF).

9797852

Rodin DA

1998

Polycystic ovaries and associated metabolic abnormalities in Indian subcontinent Asian women.

9798131

Erel CT

1998

Adrenal androgenic response to 2-hour ACTH stimulation test in women with PCOS.

9798138

Ciampelli M

1998

Insulin and polycystic ovary syndrome: a new look at an old subject.

9800673

Kaleli S

1998

Ovarian stromal hypertrophy in polycystic ovary syndrome.

9804215

Magoffin DA

1998

Inhibin A, inhibin B and activin A concentrations in follicular fluid from women with polycystic ovary syndrome.

9804218

Dahlgren E

1998

Effects of two antiandrogen treatments on hirsutism and insulin sensitivity in women with polycystic ovary syndrome.

9806289

Watson H

1998

Regulation of epidermal growth factor receptor by androgens in human endometrial cells in culture.

9806557

Nestler JE

1998

Polycystic ovary syndrome: a disorder for the generalist.

9806564

Andoh K

1998

A comparative study of fixed-dose, step-down, and low-dose step-up regimens of human menopausal gonadotropin for patients with polycystic ovary syndrome.

9808388

Jirecek S

1998

Ovarian hyperstimulation syndrome caused by GnRH-analogue treatment without gonadotropin therapy in a patient with polycystic ovarian syndrome.

9809695

Hunter SJ

1998

Insulin action and insulin resistance: diseases involving defects in insulin receptors, signal transduction, and the glucose transport effector system.

9810132

D?chaud H

1998

[Obesity and assisted reproduction techniques].